As PSA values above 4 ng/mL are used as a biopsy indicator; [21] circulating CD117 expression could be an additional minimally invasive test with PSA to identify patients likely to have locally advanced prostate cancer. This evidence concerns the gene KIT and Familial prostate cancer.